Skip to content

Clinical trials

Phase 2 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2 Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20071
20082
20096
20103
20112
20121
20132
20143
20151
20165
20173
20182
20193
20203
20212
20223
20237
20245
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Unknown status6
Terminated6
Withdrawn5
Active, not recruiting5
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Medicago6
National Center for Research Resources (NCRR)5
Pfizer4
Upstream Bio Inc.3
Cardeas Pharma2
InSilico Medicine Hong Kong Limited2
Sichuan Cancer Hospital and Research Institute2
Vertex Pharmaceuticals Incorporated2
Altair Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases69
Lung Diseases36
Respiratory Tract Infections21
Virus Diseases15
Asthma12
Infections11
RNA Virus Infections11
Influenza, Human10
Bronchial Diseases9
Neoplasms9

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.